HIGHLIGHTS
- who: Qin Tang et al. from the Department of Obstetrics and Gynecology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China have published the research work: Comparative Survival Outcomes of Hyperthermic Intraperitoneal Chemotherapy, Intraperitoneal Chemotherapy and Intravenous Chemotherapy for Primary Advanced Ovarian Cancer: A Network Meta-Analysis, in the Journal: (JOURNAL) of 15/08/2022
- what: The authors aimed to compare the outcomes and adverse events of hyperthermic (HIPEC) (IP)and intravenous (IP)for primary advanced ovarian cancer.
- how: The analysis results showed that HIPEC2 (carboplatin with area under the curve 10 . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.